Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Nanopore Technologies Regulatory News (ONT)

Share Price Information for Oxford Nanopore Technologies (ONT)

Share Price is delayed by 15 minutes
Get Live Data
130.90    0.60 (0.46%)
Bid:
130.90
Ask:
133.00
Spread: 2.10 (1.604%)
Market Cap: £1.27b
ONT Live PriceLast checked at - London Stock Exchange

Intraday Oxford Nanopore Technologies Share Chart

Total Voting Rights

5 Oct 2021 15:45

RNS Number : 1036O
Oxford Nanopore Technologies plc
05 October 2021
Β 

5 October 2021

Oxford Nanopore Technologies plc (the "Company")

Total Voting Rights

In accordance with the Financial Conduct Authority's Disclosure, Guidance and Transparency Rules 5.6.1A, the Company announces that as at the date of this announcement, the Company's issued share capital consists of 794,668,860 ordinary shares of Β£0.0001 each, all with voting rights. The Company holds no ordinary shares in Treasury.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure, Guidance and Transparency Rules.

For further information, please contact:

Oxford Nanopore Technologies plc

media@nanoporetech.com

Tulchan Group (communications adviser to the Company)

Tom Murray, Olivia Peters, Deborah Roney

+44 (0) 20 7353 4200 OxfordNanopore@tulchangroup.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TVREALESEDNFFFA
Date   Source Headline
12th Jun 20237:00 amRNSNational German rare disease study
9th Jun 20237:00 amRNSChange of Broker
1st Jun 20233:00 pmRNSIssue of Equity and Total Voting Rights
19th May 20237:00 amRNSLondon Calling Technology Update
12th May 20231:30 pmRNSHolding(s) in Company
12th May 20238:35 amRNSNext step of PathoQuest strategic collaboration
11th May 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
4th May 20234:30 pmRNSDirector/PDMR Notification
2nd May 20233:00 pmRNSIssue of Equity and Total Voting Rights
26th Apr 20237:00 amRNSPublication of Annual Report and Notice of AGM
17th Apr 20237:00 amRNSNew infectious disease partnership with bioMerieux
13th Apr 20236:00 pmRNSDirector/PDMR Shareholding
12th Apr 20234:00 pmRNSLTIP and DBP; Director/PDMR Notification
12th Apr 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
11th Apr 20237:00 amRNSNIH Alzheimers study shows scaled, accurate data
6th Apr 20234:00 pmRNSBlock listing Interim Review
3rd Apr 20233:30 pmRNSIssue of Equity and Total Voting Rights
31st Mar 20237:00 amRNSNIHR, Oxford Nanopore announce new health study
21st Mar 20237:00 amRNSFinal results for the year ended 31 December 2022
13th Mar 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
9th Mar 20237:00 amRNSNotice of Results
1st Mar 20233:30 pmRNSIssue of Equity and Total Voting Rights
27th Feb 20236:00 pmRNSChanges to Director Roles and Responsibilities
13th Feb 20235:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Feb 20234:30 pmRNSTotal Voting Rights and Issue of Equity
17th Jan 20237:00 amRNSTrading update
13th Jan 20233:30 pmRNSDirector/PDMR Shareholding (ESPP)
11th Jan 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
4th Jan 20235:30 pmRNSDirector/PDMR Shareholding (ESPP)
3rd Jan 20235:00 pmRNSIssue of equity and Total Voting Rights
28th Dec 20223:00 pmRNSHolding(s) in Company
23rd Dec 202212:00 pmRNSHolding(s) in Company
13th Dec 20224:50 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Dec 20223:00 pmRNSIssue of Equity and Total Voting Rights
11th Nov 20224:30 pmRNSDirector/PDMR Shareholding
11th Nov 20224:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Nov 20225:00 pmRNSIssue of Equity and Total Voting Rights
11th Oct 20224:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
10th Oct 202212:00 pmRNSDirector/PDMR Shareholding
6th Oct 20225:30 pmRNSBlock listing Interim Review
3rd Oct 20225:00 pmRNSIssue of Equity and Total Voting Rights
29th Sep 20229:00 amRNSDirector/PDMR Shareholding
14th Sep 202211:00 amRNSDirector/PDMR Shareholding
13th Sep 20225:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
13th Sep 20227:00 amRNSInterim results for the period ended 30 June 2022
12th Sep 20224:30 pmRNSOxford Nanopore to present at upcoming conferences
1st Sep 20226:30 pmRNSIssue of Equity and Total Voting Rights
24th Aug 20227:00 amRNSNotice of Results
11th Aug 20224:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Aug 20225:30 pmRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.